Suffering from acne is difficult enough, but for many people the condition is made even worse by unsightly scars left by blemishes. Although there are several treatments that claim to diminish acne scars, Rhytec, Inc.'s Portrait PSR3 Plasma system offers less downtime then fractional lasers on the market and was recently approved by the U.S. Food and Drug Administration (FDA) for use in treating acne scars.

Portrait Plasma was previously approved by the FDA for reducing the appearance of wrinkles and for treating superficial skin lesions and other skin conditions. Recent studies found that the system also improved acne scarring by 23%-29% within six months after only one treatment, with sustained results for up to two years.

The Portrait Plasma system is a unique, non-invasive procedure that uses nitrogen plasma energy to stimulate natural regeneration of collagen in the skin. Unlike lasers that only target certain layers of the skin, Plasma treats 100% of the skin, both at and below the surface. Plasma also offers less downtime and little to no risk of hypopigmentation, scarring or discoloration.

Founded in 2004, Rhytec, Inc. works with leading dermatologists, plastic surgeons, and cosmetic physicians to develop new technologies that enhance the skin's appearance and function.